This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- Thomas B. Russell, MD*
- David E. Kram, MD, MCR*
- *Section of Pediatric Hematology/Oncology, Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC
AUTHOR DISCLOSURE
Drs Russell and Kram have disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
- AKI:
- acute kidney injury
- ALL:
- acute lymphoblastic leukemia
- HRD:
- high-risk disease
- IRD:
- intermediate-risk disease
- LRD:
- low-risk disease
- TLS:
- tumor lysis syndrome
Practice Gaps
Along with knowledge of how to evaluate a pediatric patient with a suspected malignancy, general pediatricians must maintain a high level of suspicion of tumor lysis syndrome for initial management and timely patient referral. This syndrome is largely preventable, and certainly manageable, with prompt diagnosis and appropriate intervention.
Objectives
After completing this article, readers should be able to:
Define and diagnose tumor lysis syndrome (TLS).
Recognize the risk factors for TLS.
Stratify pediatric patients with cancer according to risk of developing TLS.
Identify interventions to prevent TLS.
Discuss management strategies for patients with TLS.
Introduction
Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency that occurs when cancer cells break down, either spontaneously or after initiation of cytotoxic chemotherapy, and release their intracellular contents into the bloodstream. This massive release of uric acid, potassium, and phosphorous, which under normal physiologic conditions are excreted in the urine, can lead to hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. These metabolic derangements increase the risk of severe complications, including acute kidney injury (AKI), cardiac arrhythmias, seizures, and even death. TLS is the most common oncologic emergency, and it occurs most frequently in children with acute leukemia and non-Hodgkin lymphoma. TLS is often preventable; clinicians must maintain a high index of suspicion and rely on effective prevention and treatment strategies. This review will serve to update the readership on TLS in pediatric oncology patients, including the definition, common risk factors, epidemiology, pathophysiology, and clinical consequences, as well as preventive and management measures for children with suspected or newly diagnosed cancers.
Definition of TLS
TLS consists of a constellation of laboratory findings, including hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia and the consequential clinical …
Log in using your username and password
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.